None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Male and females with visible grey hair greater than or equal to 30 percent 2. Willingness to use only assigned product during study. 3. No active scalp disease or severe dermatological condition. 4. Subjects who are willing to give informed consent and ready to comply with the protocol
Exclusion criteria
Exclusion criteria: 1. Subject with severe dermatological disorders of the scalp that might interfere with the study evaluation 2. Subjects who have used hair dye products over the last 2 months. 3. Known cases of Hypersensitivity to any ingredient of dye. 4. History of severe allergic scalp reactions. 5. Recent use of systemic corticosteroids or immunosuppressants. 6. Pregnant or lactating women. 7. Subjects who have participated in any other clinical study since last 3 months 8. Any other condition due to which patients are deemed to be unsuitable by the investigator for reason(s) not specifically started in the exclusion criteria.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Colour coverage (grey hair coverage, uniformity, intensity) 2.Time (mins) taken by hair dye and hair colour shampoo to colour coverage (grey hair coverage, uniformity, intensity) immediately post application. Timepoint: Screening Baseline Visit (Day 0), Follow up Visit 1 Day 1 (24 hrs. post skin patch test application, visit 2 (48 hrs. post skin patch test application, Follow Up Visit 3 (Week 2), Follow Up Visit 4 (Week 4), Follow Up Visit 5 (Week 5), Follow Up Visit 6 (Week 6) | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Skin patch test using Dermal Response Score. 2. Tolerability (scalp irritation, allergic response, dermatological adverse events) of hair dye and hair dye shampoo. 3. Requirement of reapplication of hair dye and hair colour shampoo (number of days) and assessment of hair damage (thinning, breakage fall, roughness, dryness -yes or no) due to repeated application of hair dye and hair colour shampoo 4. Color retention or fading 5. Hair quality (shine or gloss, texture or smoothness, hair breakage or dryness) 6. User satisfaction and convenience (ease of use, odour, staining, wash-off) 7. Global assessment of overall change by investigator and subjects 8. Tolerability of study products by investigator and subjects 9. Adverse events and adverse drug reaction including vitalsTimepoint: Screening Baseline Visit (Day 0), Follow up Visit 1 Day 1 (24 hrs. post skin patch test application, visit 2 (48 hrs. post skin patch test application, Follow Up Visit 3 (Week 2), Follow Up Visit 4 (Week 4), Follow Up Visit 5 (Week 5), Follow Up Visit 6 (Week 6) | — |
Countries
India
Contacts
Target Institute of Medical Education and Research Pvt. Ltd